1. Wang H, Shi H, He X, LiaoA. Downregulation of Chemokine CCL20 Involved in Myeloma Cells Resistant toElotuzumab and Lenalidomide. Onco Targets Ther. 2021 Apr 21;14:2789-2795. 通讯作者 IF 4.345

2. Ma H, Wang H, Tian F, Zhong Y, Liu Z, Liao A.PIWI-InteractingRNA-004800 Is Regulated by S1P Receptor Signaling Pathway to Keep Myeloma CellSurvival Front Oncol. 2020 Apr 15;10:438. doi: 10.3389/fonc.2020.00438. 通讯作者 IF6.244 

3. Zhong Y, TianF, Ma H, Wang H, Yang W, Liu Z, Liao A. FTY720 induces ferroptosis andautophagy via PP2A/AMPK pathway in multiple myeloma cells. Life Sci. 2020 Aug15;260:118077. doi: 10.1016/j.lfs.2020.118077. 通讯作者  IF 5.035 

4. Tian F, Wang H,Ma H, Zhong Y, Liao A. miR‑144‑3p inhibits the proliferation, migrationand angiogenesis of multiple myeloma cells by targeting myocyte enhancer factor2A. Int J Mol Med. 2020 Sep;46(3):1155-1165. 通讯作者IF 4.101 

5. Yang R, HuangJ, Ma H, Li S, Gao X, Liu Y, Shen J, Liao A. Is complement C1q a potentialmarker for tumor burden and immunodeficiency in multiple myeloma? LeukLymphoma. 2019 Jul;60(7):1812-1818. 通讯作者IF 2.969 

6. Fu D, Li Y, Li J, Shi X, Yang R, Zhong Y, Wang H, LiaoA.The effect of S1P receptor signaling pathway on the survival and drug resistancein multiple myeloma cells.Mol Cell Biochem. 2017 Jan; 424(1-2): 185 -193.通讯作者 IF 2.561

7.Liao A, Hu R, Zhao Q, Li J, Li Y, Yao K, Zhang R, WangH, Yang W, Liu Z. Autophagy induced by FTY720 promotes apoptosis in U266 cells.European Journal of Pharmaceutical sciences. 2012，45(5):600-605.  IF2.987

8.Liao A, Broeg K, Fox T, Tan SF, Watters R, Shah MV,Zhang LQ, Li Y, Ryland L, Yang J, Aliaga C, Dewey A, Rogers A, Loughran K,Hirsch L, Jarbadan NR, Baab KT, Liao J, Wang HG, Kester M, Desai D, Amin S,Loughran TP Jr, Liu X. Therapeutic efficacy of FTY720 in a rat model of NK-cellleukemia. Blood. 2011 , 118(10):2793-800. IF 9.898